Skip to content
Non-Current Assets

AFS Securities

Medtronic AFS Securities increased by 7.0% to $3.13B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $3.19B to $3.13B.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2015
Last reportedQ3 2026Feb 24, 2026
Metric ID: fin_afs_securities

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$2.98B$3.2B$3.34B$3.6B$3.65B$3.71B$3.8B$3.74B$3.71B$3.33B$3.25B$3.19B$3.02B$2.92B$3.13B
QoQ Change+7.4%+4.3%+7.8%+1.4%+1.6%+2.5%-1.6%-0.8%-10.3%-2.3%-1.9%-5.3%-3.1%+7.0%
YoY Change+20.8%+14.1%+11.1%+5.6%+2.4%+0.0%-12.5%-13.1%-14.1%-9.3%-10.1%-1.9%
Range$2.92B$3.8B
CAGR+1.4%
Avg YoY Growth-0.6%
Median YoY Growth-0.9%

AFS Securities at Other Companies

Frequently Asked Questions

What is Medtronic's afs securities?
Medtronic (MDT) reported afs securities of $3.13B in Q4 2025.
How has Medtronic's afs securities changed year-over-year?
Medtronic's afs securities decreased by 1.9% year-over-year, from $3.19B to $3.13B.